In hypertrophic cardiomyopathy (HCM), papillary muscle displacement along with associated leaflet elongation can contribute to systolic anterior motion (SAM). Septal hypertrophy in HCM narrows left ventricular outflow tract (LVOT) and creates Venturi effect during systole dragging mitral valve into the LVOT. 1 Mitral valve has adaptive reserve which prevents SAM. Systolic anterior motion is a result of complex geometric interaction between mitral valve components requiring significant Venturi and drag forces in the presence of good functioning left ventricle (LV). Disruption in dynamic mitral valvular apparatus, eg, after mitral valve repair can produce SAM. 'Drag' phenomenon is believed to be the most predominant cause of SAM, rather than Venturi.
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Predisposing factors that cause SAM are (1) excessive anterior or posterior leaflet tissue; (2) any anatomical or surgical translocation of the mitral valve anteriorly; (3) aortomitral angle <120° (Figure 1 ; Supplementary Clip 1); (4) pathological or post-surgical correction elongation of the anterior leaflet; (5) annular undersizing in mitral valve repair; (6) chordal anomalies such as elongation and buckling; (7) surgical chordal interventions such as transection, translocation, and reimplantation; (8) anterior and medial displacement of the papillary muscles; (9) bulging subaortic septum; (10) absolute height of the posterior leaflet (>1.5 cm); (11) anterior to posterior leaflet height ratio (<1.4); and (12) minimum distance from the coaptation point to the septum (C-Sept, <2.5 cm). 2 In non-HCM hypertrophied ventricles, SAM peak is observed at the end of systole; however, SAM peaks in midsystole in patients with HCM. 3 Systolic anterior motion of mitral leaflet is more likely to happen when anatomically susceptible heart is subjected to permissive physiological conditions that provoke SAM: ie, reduced preload, increased inotropic state, and decreased afterload. Complex congenital conditions such as accessory papillary muscle, cleft anterior mitral leaflet, subaortic stenosis, 4 and transposition of the great arteries 5 can also present SAM. Systolic anterior motion in post-aortic valve replacement (AVR) patients with pre-existing aortic stenosis can be observed due to drag on the anterior mitral leaflet because of raised blood velocity in the LVOT and small hypertrophied LV cavity. 6 Paradoxically, SAM is uncommon in post-AVR patients operated for aortic regurgitation due to dilated LV with increased distance between mitral valve and LVOT and compensatory hypervolemia seen in these patients. 7 Takotsubo cardiomyopathy rarely can present with SAM and left ventricular outflow tract obstructions because of mid and apical hypokinesia and compensatory basal hyperkinesias. 8 Patients with diabetes may manifest SAM in the context of LV hypertrophy due to hyperdynamic state by raised β-adrenoreceptor sensitivity. 9 Dobutamine stress echocardiography has also been reported to cause SAM by alteration of pathoanatomical features of mitral valve. 10 It is like unmasking of anatomical features eliciting systolic movement of anterior 2 Clinical Medicine Insights: Cardiology mitral leaflet into LVOT. 2 Post-myocardial infarction (MI) change in LV geometry due to opposition of hyperkinetic and hypokinetic regions after acute MI can sometimes result in SAM. 11 This is clinically important because vasodilator and inotropic agents used in cardiogenic shock can actually worsen hemodynamics in such patients. Judicious use of β-blocker may benefit such patients. 2 General anaesthesia, by its effect of vasodilation and hypovolemia, can sometimes provoke SAM even in the absence of any cardiac abnormality. 2, 12 Certain cardiac surgical procedures such as mitral valve repair can cause severe systolic anterior motion of mitral apparatus resulting in grade 2 to 4 mitral regurgitation (MR) with reported incidence of 9.1%. However correction of hyperdynamic status resolved SAM and reduced MR in more than half of these patients without further operative interventions. 13 Risk assessment in patients with SAM is essential to decide WHICH SAM is clinically significant. Some methods are suggested: (1) tests to ameliorate SAM -administer fluid and vasopressor and look for reduction in SAM; (2) test to provoke SAM -administer nitroglycerin and rapid ventricular pacing and look for LVOT gradient. 2 Pathophysiology of SAM clearly indicates that anatomically susceptible heart when subjected to hypovolemia, tachycardia, and reduced afterload can easily cause LV outflow obstruction with refractory hypotension. In patients with only mild SAM and MR, conservative medical therapy by volume administration, vasoconstriction, and β-blocker can be used to stabilize the patient. However, in cases with moderate or severe SAM and MR, medical therapy may be able to reduce SAM, but surgical options to address the underlying pathology causing SAM should be preferred to avoid long-term detrimental outcomes. 2 It is essential for the perioperative physician to be aware of the variety of underlying conditions causing SAM and its clinical significance. 
